Skip to main content

Avantor, Inc.

corporate_fare Company Profile

Avantor, Inc.

AVTR·NYSE·Industrial Applications And Services·CIK 0001722482

Avantor is a global provider of essential products and services for customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials sectors. The company supports customers from the initial discovery phase through to product delivery, integrating into research, scale-up, and manufacturing activities. Avantor operates through two main business approaches. First, its VWR channel business distributes consumables and equipment to laboratories worldwide. The VWR channel includes a private label offering for over 5,000 suppliers, millions of product items from major life sciences suppliers, and value-added services provided by approximately 2,000 associates. Second, Avantor manufactures its own specialized products for life sciences and medical technology. This includes J.T. Baker high-purity chemicals, Masterflex fluid handling products, and NuSil high-purity silicone for human implants. Avantor serves over 300,000 customer locations in approximately 180 countries. The company's origins trace back to the J.T. Baker Chemical Company, founded in 1904. In 2010, Avantor was acquired by New Mountain Capital from Covidien plc.

Avantor, Inc. (NYSE:AVTR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for AVTR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-29, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for AVTR spans 10-Q, 8-K, DEF 14A, 4.

Recent high-impact activity:

  • Avantor Q2 Earnings Plunge on Tax Hit; Goodwill Impairment Risk Looms Over VWR Unit
  • Avantor Raises FY 2026 Organic Revenue Growth Guidance to -0.5% to +0.5% After Q2 Beat
  • Avantor Lifts 2026 Organic Growth Outlook, Now Sees Up to +0.5%
  • Avantor Reports Significant Q1 Profit Decline, Warns of High Goodwill Impairment Risk
  • Avantor Beats Q1 Adjusted EPS, Reaffirms Full-Year Guidance Amidst Organic Sales Decline

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$6.55B
Net Income
-$530.2M
Diluted EPS
-$0.78
Op. Cash Flow
$623.8M
Free Cash Flow
$495M
Gross Profit
$2.14B
Operating Income
-$246.2M
Cash & Equivalents
$365.4M
Total Debt
$3.95B
Debt / Equity
0.71×
Net Margin
-8.1%
Shares Outstanding
682M sh
Source: 10-K · filed 2026-02-11 · accession 0001628280-26-007118

Short Interest & Short Volume

6.19 days to cover

FINRA reported short interest of 51,373,338 shares in AVTR as of the September 15, 2026 settlement, a 2.3% increase from the prior period — about 6.2 days to cover at its recent average daily volume. On October 2, 2026, 46.1% of AVTR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)51,373,338 shares as of September 15, 2026
Change vs prior period▲ 2.3%
Days to cover6.19 at avg daily volume of 8,295,797
Daily short volume (FINRA facilities)46.1% of 2,039,389 shares on October 2, 2026
5-day average short volume43.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$15.34
52-week range · as of 2026-07-29 $7.26 – $15.93
Market cap
$10.38B
Volume
6.1M (0.8× avg)
3-mo avg 8.1M
Live data · 2026-10-05 04:23 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed AVTR - Latest Insights

AVTR
Jul 29, 2026, 9:01 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.76
Real-time Price: $15.34 info
Change: +$1.58 (+11%) info
Market Cap: $10.375B info
AVTR
Jul 29, 2026, 6:13 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.40
Real-time Price: $15.34 info
Change: +$1.94 (+14%) info
Market Cap: $10.375B info
AVTR
Jul 29, 2026, 6:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.90
Real-time Price: $15.34 info
Change: +$2.44 (+19%) info
Market Cap: $10.375B info
AVTR
Apr 29, 2026, 9:02 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.34
Real-time Price: $15.34 info
Change: +$7.00 (+84%) info
Market Cap: $10.375B info
AVTR
Apr 29, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $15.34 info
Change: +$6.84 (+80%) info
Market Cap: $10.375B info
AVTR
Apr 29, 2026, 6:05 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.91
Real-time Price: $15.34 info
Change: +$7.43 (+94%) info
Market Cap: $10.375B info
AVTR
Apr 23, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.70
Real-time Price: $15.34 info
Change: +$7.64 (+99%) info
Market Cap: $10.375B info
AVTR
Apr 01, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.87
Real-time Price: $15.34 info
Change: +$7.47 (+95%) info
Market Cap: $10.375B info
AVTR
Mar 27, 2026, 7:40 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $7.63
Real-time Price: $15.34 info
Change: +$7.71 (+101%) info
Market Cap: $10.375B info
AVTR
Feb 12, 2026, 5:24 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $9.17
Real-time Price: $15.34 info
Change: +$6.17 (+67%) info
Market Cap: $10.375B info
AVTR
Feb 11, 2026, 7:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.87
Real-time Price: $15.34 info
Change: +$5.47 (+55%) info
Market Cap: $10.375B info
AVTR
Feb 11, 2026, 7:34 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $9.83
Real-time Price: $15.34 info
Change: +$5.51 (+56%) info
Market Cap: $10.375B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets